Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 18-Nov-24 9:50 PM View:  | Goldshleger Ilya See remarks | Rxsight, Inc. (RXST) | 18-Nov-24 | Option Exercise | 3,100 | $15.08 | $46,748.00 | 7% 43.62K to 46.72K | |
| 18-Nov-24 9:50 PM View: | Goldshleger Ilya See remarks | Rxsight, Inc. (RXST) | 18-Nov-24 | Planned Option Sale | 3,100 | $45.00 | $139,502.00 | (7%) 46.72K to 43.62K | |
| 18-Nov-24 9:50 PM View: | Goldshleger Ilya See remarks | Rxsight, Inc. (RXST) | 15-Nov-24 | Option Exercise | 4,875 | $15.08 | $73,515.00 | 11% 43.62K to 48.49K | |
| 18-Nov-24 9:50 PM View: | Goldshleger Ilya See remarks | Rxsight, Inc. (RXST) | 15-Nov-24 | Planned Option Sale | 4,875 | $46.00 | $224,250.00 | (10%) 48.49K to 43.62K | |
| 14-Nov-24 7:14 PM View: | Corley Jesse Anderson Director | Rxsight, Inc. (RXST) | 13-Nov-24 | Purchase | 5,795 | $44.84 | $259,841.00 | 1% 532.58K to 538.37K | |
| 14-Nov-24 7:14 PM View: | Corley Jesse Anderson Director | Rxsight, Inc. (RXST) | 13-Nov-24 | Purchase | 5,570 | $45.00 | $250,650.00 | 1% 527.0K to 532.58K | |
| 14-Nov-24 7:14 PM View: | Corley Jesse Anderson Director | Rxsight, Inc. (RXST) | 12-Nov-24 | Purchase | 11,111 | $45.37 | $504,079.00 | 2% 515.89K to 527.0K | |
| 14-Nov-24 7:42 PM View: | Goldshleger Ilya See remarks | Rxsight, Inc. (RXST) | 12-Nov-24 | Option Exercise | 1,330 | $15.08 | $20,056.40 | 3% 43.62K to 44.95K | |
| 14-Nov-24 7:42 PM View: | Goldshleger Ilya See remarks | Rxsight, Inc. (RXST) | 12-Nov-24 | Planned Option Sale | 1,330 | $46.13 | $61,356.20 | (3%) 44.95K to 43.62K | |
| 15-Oct-24 4:23 PM View: | Goldshleger Ilya See remarks | Rxsight, Inc. (RXST) | 14-Oct-24 | Planned Option Sale | 3,100 | $50.09 | $155,268.00 | (7%) 46.72K to 43.62K | |
| 15-Oct-24 4:23 PM View: | Goldshleger Ilya See remarks | Rxsight, Inc. (RXST) | 14-Oct-24 | Option Exercise | 3,100 | $15.08 | $46,748.00 | 7% 43.62K to 46.72K | |
| 15-Oct-24 4:23 PM View: | Goldshleger Ilya See remarks | Rxsight, Inc. (RXST) | 11-Oct-24 | Option Exercise | 3,100 | $15.08 | $46,748.00 | 7% 43.62K to 46.72K | |
| 15-Oct-24 4:23 PM View: | Goldshleger Ilya See remarks | Rxsight, Inc. (RXST) | 11-Oct-24 | Planned Option Sale | 3,100 | $50.19 | $155,594.00 | (7%) 46.72K to 43.62K | |
| 15-Oct-24 4:23 PM View: | Goldshleger Ilya See remarks | Rxsight, Inc. (RXST) | 10-Oct-24 | Option Exercise | 3,105 | $15.08 | $46,823.40 | 7% 43.62K to 46.72K | |
| 15-Oct-24 4:23 PM View: | Goldshleger Ilya See remarks | Rxsight, Inc. (RXST) | 10-Oct-24 | Planned Option Sale | 3,105 | $48.82 | $151,596.00 | (7%) 46.72K to 43.62K | |
| 08-Oct-24 6:00 PM View: | Goldshleger Ilya See remarks | Rxsight, Inc. (RXST) | 08-Oct-24 | Planned Option Sale | 3,100 | $48.26 | $149,612.00 | (7%) 46.72K to 43.62K | |
| 08-Oct-24 6:00 PM View: | Goldshleger Ilya See remarks | Rxsight, Inc. (RXST) | 08-Oct-24 | Option Exercise | 3,100 | $15.08 | $46,748.00 | 7% 43.62K to 46.72K | |
| 08-Oct-24 6:00 PM View: | Goldshleger Ilya See remarks | Rxsight, Inc. (RXST) | 04-Oct-24 | Option Exercise | 3,100 | $15.08 | $46,748.00 | 7% 43.62K to 46.72K | |
| 08-Oct-24 6:00 PM View: | Goldshleger Ilya See remarks | Rxsight, Inc. (RXST) | 04-Oct-24 | Planned Option Sale | 3,100 | $48.01 | $148,824.00 | (7%) 46.72K to 43.62K | |
| 02-Oct-24 4:11 PM View: | Thunen Shelley B See remarks | Rxsight, Inc. (RXST) | 01-Oct-24 | Option Exercise | 15,000 | $16.00 | $240,000.00 | 49% 30.44K to 45.44K | |
| 02-Oct-24 4:11 PM View: | Thunen Shelley B See remarks | Rxsight, Inc. (RXST) | 01-Oct-24 | Planned Option Sale | 15,000 | $48.45 | $726,730.00 | (33%) 45.44K to 30.44K | |
| 30-Sep-24 8:05 PM View: | Goldshleger Ilya See remarks | Rxsight, Inc. (RXST) | 30-Sep-24 | Option Exercise | 3,100 | $15.08 | $46,748.00 | 7% 43.62K to 46.72K | |
| 30-Sep-24 8:05 PM View: | Goldshleger Ilya See remarks | Rxsight, Inc. (RXST) | 30-Sep-24 | Planned Option Sale | 3,100 | $49.01 | $151,947.00 | (7%) 46.72K to 43.62K | |
| 30-Sep-24 8:05 PM View: | Goldshleger Ilya See remarks | Rxsight, Inc. (RXST) | 26-Sep-24 | Planned Option Sale | 3,105 | $49.29 | $153,054.00 | (7%) 46.72K to 43.62K | |
| 30-Sep-24 8:05 PM View: | Goldshleger Ilya See remarks | Rxsight, Inc. (RXST) | 26-Sep-24 | Option Exercise | 3,105 | $15.08 | $46,823.40 | 7% 43.62K to 46.72K | |
| 23-Sep-24 6:48 PM View: | Goldshleger Ilya See remarks | Rxsight, Inc. (RXST) | 23-Sep-24 | Option Exercise | 3,100 | $15.08 | $46,748.00 | 7% 43.62K to 46.72K | |
| 23-Sep-24 6:48 PM View: | Goldshleger Ilya See remarks | Rxsight, Inc. (RXST) | 23-Sep-24 | Planned Option Sale | 3,100 | $52.67 | $163,263.00 | (7%) 46.72K to 43.62K | |
| 23-Sep-24 6:48 PM View: | Goldshleger Ilya See remarks | Rxsight, Inc. (RXST) | 20-Sep-24 | Planned Option Sale | 3,100 | $53.19 | $164,901.00 | (7%) 46.72K to 43.62K | |
| 23-Sep-24 6:48 PM View: | Goldshleger Ilya See remarks | Rxsight, Inc. (RXST) | 20-Sep-24 | Option Exercise | 3,100 | $15.08 | $46,748.00 | 7% 43.62K to 46.72K | |
| 18-Sep-24 4:41 PM View: | Goldshleger Ilya See remarks | Rxsight, Inc. (RXST) | 17-Sep-24 | Planned Option Sale | 3,100 | $56.11 | $173,944.00 | (7%) 46.72K to 43.62K | |
| 18-Sep-24 4:41 PM View: | Goldshleger Ilya See remarks | Rxsight, Inc. (RXST) | 17-Sep-24 | Option Exercise | 3,100 | $15.08 | $46,748.00 | 7% 43.62K to 46.72K | |
| 09-Aug-24 5:57 PM View: | Kurtz Ronald M Md President & CEO Director | Rxsight, Inc. (RXST) | 09-Aug-24 | Option Exercise | 9,950 | $12.60 | $125,355.00 | 1% 818.11K to 828.06K | (9%) |
| 06-Aug-24 4:19 PM View: | Goldshleger Ilya See remarks | Rxsight, Inc. (RXST) | 05-Aug-24 | Private Sale (Planned) | 9,000 | $39.25 | $353,291.00 | (17%) 52.62K to 43.62K | |
| 16-Jul-24 8:15 PM View: | Thunen Shelley B See remarks | Rxsight, Inc. (RXST) | 15-Jul-24 | Option Exercise | 16,505 | $4.34 | $71,631.70 | 118% 13.94K to 30.44K | |
| 12-Jul-24 7:12 PM View: | Kurtz Ronald M Md President & CEO Director | Rxsight, Inc. (RXST) | 11-Jul-24 | Option Exercise | 13,500 | $15.08 | $203,604.00 | 2% 804.61K to 818.11K | |
| 02-Jul-24 4:25 PM View: | Thunen Shelley B Chief Financial Officer | Rxsight, Inc. (RXST) | 01-Jul-24 | Option Exercise | 10,000 | $15.60 | $155,983.00 | 45% 22.34K to 32.34K | |
| 02-Jul-24 4:25 PM View: | Thunen Shelley B Chief Financial Officer | Rxsight, Inc. (RXST) | 01-Jul-24 | Planned Option Sale | 10,000 | $58.61 | $586,055.00 | (31%) 32.34K to 22.34K | |
| 02-Jul-24 4:25 PM View: | Thunen Shelley B Chief Financial Officer | Rxsight, Inc. (RXST) | 01-Jul-24 | Sale (Planned) | 8,402 | $58.77 | $493,760.00 | (38%) 22.34K to 13.94K | |
| 17-Jun-24 6:45 PM View: | Andrews Julie Director | Rxsight, Inc. (RXST) | 14-Jun-24 | Private Sale (Planned) | 15,625 | $58.00 | $906,288.00 | (34%) 45.91K to 30.29K | |
| 10-Jun-24 4:11 PM View: | Corley Jesse Anderson Director | Rxsight, Inc. (RXST) | 06-Jun-24 | Grant | 2,554 | -- | -- | < 1% 513.34K to 515.89K | |
| 10-Jun-24 4:05 PM View: | Andrews Julie Director | Rxsight, Inc. (RXST) | 06-Jun-24 | Grant | 2,554 | -- | -- | 6% 43.36K to 45.91K | |
| 10-Jun-24 4:20 PM View: | Maniar Shweta Director | Rxsight, Inc. (RXST) | 06-Jun-24 | Grant | 2,554 | -- | -- | 21% 12.13K to 14.68K | |
| 10-Jun-24 4:07 PM View: | Tammenoms Bakker Juliet Director | Rxsight, Inc. (RXST) | 06-Jun-24 | Grant | 2,554 | -- | -- | 7% 36.39K to 38.94K | |
| 10-Jun-24 4:25 PM View: | Warner Robert Keith Director | Rxsight, Inc. (RXST) | 06-Jun-24 | Grant | 2,554 | -- | -- | 9% 27.73K to 30.29K | |
| 10-Jun-24 4:17 PM View: | Link William J Phd Director | Rxsight, Inc. (RXST) | 06-Jun-24 | Grant | 2,554 | -- | -- | 6% 45.8K to 48.35K | |
| 10-Jun-24 4:14 PM View: | Fountain Tamara Director | Rxsight, Inc. (RXST) | 06-Jun-24 | Grant | 2,554 | -- | -- | 9% 29.24K to 31.79K | |
| 10-Jun-24 4:23 PM View: | Palmisano Robert J Director | Rxsight, Inc. (RXST) | 06-Jun-24 | Grant | 2,554 | -- | -- | 9% 27.73K to 30.29K | |
| 20-May-24 4:56 PM View: | Goldshleger Ilya Chief Operating Officer | Rxsight, Inc. (RXST) | 17-May-24 | Option Exercise | 24,771 | $4.04 | $100,066.00 | 89% 27.85K to 52.62K | |
| 21-May-24 4:11 PM View: | Tammenoms Bakker Juliet Director | Rxsight, Inc. (RXST) | 17-May-24 | Purchase | 5,000 | $61.09 | $305,456.00 | 16% 31.39K to 36.39K | |
| 06-May-24 5:02 PM View: | Kurtz Ronald M Md President & CEO Director | Rxsight, Inc. (RXST) | 03-May-24 | Private Sale (Planned) | 40,000 | $60.15 | $2,405,870.00 | (5%) 844.61K to 804.61K |
